Healthcare · Healthcare Plans · NYSE
| Market cap | $10.87B |
|---|---|
| Trailing P/E | 104.5 |
| Price / book | 2.6 |
| Price / sales | 0.3 |
| FCF yield | -5.8% |
| Dividend yield | — |
| Gross margin | 8.0% |
| Operating margin | 0.6% |
| Net margin | -0.1% |
| Revenue growth (YoY) | +11.8% |
| Revenue growth (3-yr annual) | +12.4% |
| EPS growth (YoY) | -53.0% |
| FCF/share growth (YoY) | -227.5% |
| Beta | 0.8 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Next report: Feb 4, 2027 (Q4 2026, EPS estimate $0.51). Beat the EPS estimate in 3 of 4 recent quarters.
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 21, 2026 | $0.89 | $0.79 | +12.7% | $11.08B |
| Q2 2026 | Jul 22, 2026 | $1.51 | $1.40 | +7.9% | $10.87B |
| Q1 2026 | Apr 22, 2026 | $2.35 | $1.91 | +23.0% | $10.80B |
| Q4 2025 | Feb 5, 2026 | -$2.75 | $0.33 | -933.3% | $11.38B |
Median target $222.00 from 17 analysts, ranging $163.00 – $266.00.
| Ticker | Company | Market cap | P/E |
|---|---|---|---|
| UNH | UnitedHealth Group | $353.17B | 19.3 |
| CVS | CVS Health | $107.28B | 10.1 |
| ELV | Elevance Health | $91.96B | 14.0 |
| CI | Cigna Group | $77.58B | 9.3 |
| HUM | Humana | $52.08B | 32.7 |
| CNC | Centene | $34.53B | 13.2 |
| OSCR | Oscar Health | $9.46B | 12.7 |
| PGNY | Progyny | $2.58B | 17.0 |
Molina Healthcare trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Dec 15, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | Oct 7, 2025 |
| Byron Donalds | House | Sell | $1,001 - $15,000 | Oct 7, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | Jun 9, 2025 |
| Gilbert Cisneros | House | Sell | $1,001 - $15,000 | Jun 6, 2025 |
| Gilbert Cisneros | House | Buy | $1,001 - $15,000 | May 6, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Feb 13, 2025 |
| Daniel Goldman | House | Sell | $15,001 - $50,000 | Aug 13, 2023 |